{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T10:03:32Z","timestamp":1779012212079,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM065546"],"award-info":[{"award-number":["R01GM065546"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM132640"],"award-info":[{"award-number":["R01GM132640"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.abb.2021.108852","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T04:44:32Z","timestamp":1616561072000},"page":"108852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Disease variants of human \u03941-pyrroline-5-carboxylate reductase 2 (PYCR2)"],"prefix":"10.1016","volume":"703","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1700-3350","authenticated-orcid":false,"given":"Sagar M.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Seravalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-113X","authenticated-orcid":false,"given":"John J.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-7201","authenticated-orcid":false,"given":"Donald F.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2021.108852_bib1","first-page":"567","article-title":"Evolution of plant \u03941-pyrroline-5-carboxylate reductases from phylogenetic and structural perspectives","volume":"6","author":"Forlani","year":"2015","journal-title":"Front. Plant Sci."},{"issue":"9","key":"10.1016\/j.abb.2021.108852_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045190","article-title":"Functional specialization in proline biosynthesis of melanoma","volume":"7","author":"De Ingeniis","year":"2012","journal-title":"PloS One"},{"issue":"W1","key":"10.1016\/j.abb.2021.108852_bib3","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.abb.2021.108852_bib5","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1074\/jbc.M117.780288","article-title":"Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1","volume":"292","author":"Christensen","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuron.2020.03.028","article-title":"Loss of PYCR2 causes neurodegeneration by increasing cerebral glycine levels via SHMT2","volume":"107","author":"Escande-Beillard","year":"2020","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.abb.2021.108852_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jmb.2006.04.053","article-title":"Crystal structure of human pyrroline-5-carboxylate reductase","volume":"359","author":"Meng","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2021.108852_bib8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3389\/fpls.2015.00869","article-title":"The structure of Medicago truncatula \u03941-pyrroline-5-carboxylate reductase provides new insights into regulation of proline biosynthesis in plants","volume":"6","author":"Ruszkowski","year":"2015","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.abb.2021.108852_bib9","doi-asserted-by":"crossref","first-page":"17206","DOI":"10.1038\/srep17206","article-title":"Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.abb.2021.108852_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/ars.2017.7350","article-title":"Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses, Antioxid","volume":"30","author":"Phang","year":"2019","journal-title":"Redox Signal"},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.abb.2021.108852_bib12","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.1918607117","article-title":"Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis","volume":"117","author":"Choi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.abb.2021.108852_bib13","first-page":"3815","article-title":"Identification of potential cervical cancer serum biomarkers in Thai patients","volume":"19","author":"Keeratichamroen","year":"2020","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.abb.2021.108852_bib14","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1007\/s13277-015-3927-8","article-title":"Downregulation of pyrroline-5-carboxylate reductase-2 induces the autophagy of melanoma cells via AMPK\/mTOR pathway","volume":"37","author":"Ou","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.abb.2021.108852_bib15","author":"Kniffin"},{"key":"10.1016\/j.abb.2021.108852_bib16","author":"Kniffin"},{"issue":"5","key":"10.1016\/j.abb.2021.108852_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajhg.2015.03.003","article-title":"Mutations in PYCR2, encoding pyrroline-5-carboxylate reductase 2, cause microcephaly and hypomyelination","volume":"96","author":"Nakayama","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.24678","article-title":"PYCR2 mutations cause a lethal syndrome of microcephaly and failure to thrive","volume":"80","author":"Zaki","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0003-2697(75)90408-X","article-title":"Improved chemical synthesis and enzymatic assay of \u03941-pyrroline-5-carboxylic acid","volume":"64","author":"Williams","year":"1975","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0003-2697(76)90223-2","article-title":"Properties and analysis of a stable derivative of pyrroline-5-carboxylic acid for use in metabolic studies","volume":"74","author":"Mezl","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.abb.2021.108852_bib21","series-title":"Molecular Cloning: a Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.abb.2021.108852_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1472-6750-7-32","article-title":"Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli","volume":"7","author":"de Marco","year":"2007","journal-title":"BMC Biotechnol."},{"issue":"16","key":"10.1016\/j.abb.2021.108852_bib23","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1016\/S0021-9258(18)60538-1","article-title":"Purified human erythrocyte pyrroline-5-carboxylate reductase: preferential oxidation of NADPH","volume":"264","author":"Merrill","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jmb.2005.08.036","article-title":"Crystal structures of \u03941-pyrroline-5-carboxylate reductase from human pathogens Neisseria meningitides and Streptococcus pyogenes","volume":"354","author":"Nocek","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.abb.2021.108852_bib25","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1104\/pp.99.4.1642","article-title":"Subcellular location of \u03941-pyrroline-5-carboxylate reductase in root\/nodule and leaf of soybean","volume":"99","author":"Szoke","year":"1992","journal-title":"Plant Physiol."},{"key":"10.1016\/j.abb.2021.108852_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s002840010245","article-title":"Oxidation of L-thiazolidine-4-carboxylate by \u03941-pyrroline-5-carboxylate reductase in Escherichia coli","volume":"42","author":"Deutch","year":"2001","journal-title":"Curr. Microbiol."},{"issue":"36","key":"10.1016\/j.abb.2021.108852_bib27","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.1021\/bi00036a026","article-title":"Glutamate-\u03b3-semialdehyde as a natural transition state analog inhibitor of Escherichia coli glucosamine-6-phosphate synthase","volume":"34","author":"Bearne","year":"1995","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.abb.2021.108852_bib28","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/cphc.202000464","article-title":"The bouguer-beer-lambert law: shining light on the obscure","volume":"21","author":"Mayerhofer","year":"2020","journal-title":"ChemPhysChem"},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"issue":"24","key":"10.1016\/j.abb.2021.108852_bib30","doi-asserted-by":"crossref","first-page":"E3095","DOI":"10.1073\/pnas.1500851112","article-title":"Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy","volume":"112","author":"Micsonai","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.abb.2021.108852_bib31","series-title":"Characterization of Human Pyrroline-5-Carboxylate Reductase Enzymes Responsible for L-Proline Biosynthesis, Biochemistry","first-page":"1","author":"Patel","year":"2020"},{"key":"10.1016\/j.abb.2021.108852_bib32","series-title":"Fundamentals of Enzyme Kinetics","author":"Cornish-Bowden","year":"2012"},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/14756366.2011.645240","article-title":"Classification of difference between inhibition constants of an inhibitor to facilitate identifying the inhibition type","volume":"28","author":"Yang","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molbiopara.2007.01.004","article-title":"Cryptosporidium parvum spermidine\/spermine N1-acetyltransferase exhibits different characteristics from the host enzyme","volume":"152","author":"Yarlett","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.abb.2021.108852_bib35","series-title":"Appl. No. 15\/987, 196, Pub. No. US 2019\/0031773 A1, Assignees: Bayer AG, Bayer Pharma AG, Agency for Science, Technology, and Research (Singapore)","first-page":"1","article-title":"Appl. Pub.: inhibitors and antagonists of human PYCR1","author":"Grunewald","year":"2019"},{"key":"10.1016\/j.abb.2021.108852_bib36","first-page":"4184106","article-title":"Effect of R119G mutation on human P5CR1 dynamic property and enzymatic activity","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"36","key":"10.1016\/j.abb.2021.108852_bib37","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1021\/acs.biochem.0c00490","article-title":"Cautionary tale of using tris(alkyl)phosphine reducing agents with NAD+-dependent enzymes","volume":"59","author":"Patel","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2021.108852_bib38","doi-asserted-by":"crossref","first-page":"582026","DOI":"10.3389\/fpls.2020.582026","article-title":"A specific and sensitive enzymatic assay for the quantitation of L-proline","volume":"11","author":"Forlani","year":"2020","journal-title":"Front. Plant Sci."},{"issue":"9","key":"10.1016\/j.abb.2021.108852_bib39","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1110\/ps.8.2.370","article-title":"Estimation of the number of \u03b1-helical and \u03b2-strand segments in proteins using circular dichroism spectroscopy","volume":"8","author":"Sreerama","year":"1999","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ajmg.a.38049","article-title":"Homozygous variants in pyrroline-5-carboxylate reductase 2 (PYCR2) in patients with progressive microcephaly and hypomyelinating leukodystrophy","volume":"173","author":"Meng","year":"2017","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.abb.2021.108852_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.abb.2021.108852_bib43","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1742-4658.2007.05808.x","article-title":"Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum","volume":"274","author":"Shoemark","year":"2007","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.abb.2021.108852_bib44","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jmb.2012.04.010","article-title":"The three-dimensional structural basis of type II hyperprolinemia","volume":"420","author":"Srivastava","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.abb.2021.108852_bib45","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1021\/jf0701032","article-title":"Plant P5C reductase as a new target for aminomethylenebisphosphonates","volume":"55","author":"Forlani","year":"2007","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.abb.2021.108852_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1039\/an9952001141","article-title":"Determination of free hydroxyproline and proline in human serum by high-performance liquid chromatography using 4-(5,6-dimethoxy-2-phthalimidinyl)phenylsulfonyl chloride as a pre-column fluorescent labelling reagent","volume":"120","author":"Inoue","year":"1995","journal-title":"Analyst"},{"issue":"4","key":"10.1016\/j.abb.2021.108852_bib47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bmc.3315","article-title":"Determination of proline in human serum by a robust LC-MS\/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratification","volume":"29","author":"Liang","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.abb.2021.108852_bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0026-0495(84)90215-4","article-title":"Pyrroline-5-carboxylate in human plasma","volume":"33","author":"Fleming","year":"1984","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.abb.2021.108852_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF02631111","article-title":"Accumulation of pyrroline 5-carboxylic acid in conditioned medium of cultured fibroblast: stimulatory effects of serum, insulin, and IGF-1, in Vitro Cell","volume":"27","author":"Semon","year":"1991","journal-title":"Dev. Biol. A"},{"issue":"24","key":"10.1016\/j.abb.2021.108852_bib50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.21037\/atm.2018.12.12","article-title":"Amino acid disorders","volume":"6","author":"Aliu","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.abb.2021.108852_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00431-004-1545-3","article-title":"\u03941-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline","volume":"164","author":"Baumgartner","year":"2005","journal-title":"Eur. J. Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.abb.2021.108852_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2012.03.021","article-title":"Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience","volume":"107","author":"K\u00f6lker","year":"2012","journal-title":"Mol. Genet. Metabol."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986121001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T03:46:13Z","timestamp":1723175173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986121001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":52,"alternative-id":["S0003986121001028"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2021.108852","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease variants of human \u03941-pyrroline-5-carboxylate reductase 2 (PYCR2)","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2021.108852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108852"}}